CBRE vs EOLS · P/E 43, rev $35.77B vs rev $266.3M
CBRE Group Inc Class A (CBRE) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CBRE revenue for 2024-12-31 was $35.77B. Net income was $1.04B. Revenue was up 12.0% from 2023-12-31 to 2024-12-31. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the CBRE and EOLS stock pages for the full models.
Not investment advice.